Will Section 1332 waivers be as truly transformative to our health care system? A serious, objective examination of the new Section 1332 federal guidance provides far more questions than answers for policymakers.
The Robert Wood Johnson Foundation, Altarum Institute, and Oliver Wyman consulting firm seek to better understand the challenges that vulnerable patients face in accessing health care information and to make recommendations for improving access to such information.
While Medicare and Medicaid benefit design is set by law and effectively frozen, private health care purchasers are able to innovate freely. The Urban Institute and Catalyst for Payment Reform partnered to define and categorize the payment methods and benefit designs available in the market...
A Creative Plan That Could Help Providers Ineligible For Meaningful Use Not Get Left Behind In The Paper World
Meaningful use programs have been credited with increasing adoption of EHRs, however many stakeholders are not eligible for meaningful use incentives. When care transitions involve a patchwork of paper and electronic systems, a myriad of errors emerges, and the result is substantially less than...
Two lawsuits illustrate the legal difficulties for the administration created by Congress’ limiting of ACA “risk corridor” payments---made to insurers with high claims costs---to amounts contributed to the risk corridor program by insurers with low costs.
May 24, 2016 | Following the ACA
A new policy brief from Health Affairs and the Robert Wood Johnson Foundation considers how uninsurance rates are changing under the Affordable Care Act (ACA), which was implemented to decrease the number of Americans lacking health insurance.
May 24, 2016 | Elsewhere@ Health Affairs
The concept of value-based health care is rapidly gaining traction in the U.S., yet implementation remains a significant challenge. We propose that in a true pay-for-value system, a national payment rate should be established and rooted in reality and adjusted for three factors.
Bipartisanship has been rare in Congress of late, and the House and Senate deserve praise for their efforts to reform the Toxic Substances Control Act. However, the bill that has emerged from a congressional conference committee has several important flaws.
Medicare recently delayed a plan to issue a simple “star” rating of individual hospitals’ care. However, if the hospital groups that sought this delay truly seek to sever the industry from its self-protective past, they don’t have to wait for government.